Article originally published by NeuroNews A systematic review and analysis published in the journal Interventional Neuroradiology has examined how far along “the right path” management paradigms for…

Article originally published by SpinalNews SynerFuse has announced that Michael Park (University of Minnesota, Minneapolis, USA)—principal investigator for the company’s investigational device exemption (IDE) proof-of-concept study—presented…

Article originally published by NeuroNews While a number of companies in the neurovascular space have become increasingly focused on the ‘first-pass effect’ in mechanical thrombectomy treatments, many…

Article originally published by Neuronews. A recently published Cochrane review has concluded that the clinical benefits of spinal cord stimulation (SCS) do not outweigh the risks and…

Article originally published by Neuronews. A nationwide study drawing on data from Swedish patients has indicated that—while the majority of ruptured intracranial aneurysm patients treated…

Article originally published by Neuronews. A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre…

Article originally published by Neuronews. ObvioHealth and Mi-Helper have announced a partnership to conduct a decentralised clinical trial with a small, non-invasive neuromodulation device for the…

Article originally published by Neuronews. Methinks has announced receipt of a CE mark for its artificial intelligence (AI)-based medical imaging software, Methinks Stroke Suite, following a milestone…

Article originally published by Spinal News International  Patients have a higher preoperative expectation for decompression and fusion compared to decompression alone for the treatment of…

Article originally published by St Vincent's Private Hospital Community News. We’re all for embracing our age and loving the ageing process; they’re called the golden…